| | | | | |
| €4,2763 | -4,23% | €326,75M | €256,36K | |
PHOE Phoenix Asia Holdings Limited Ordinary Shares | €15,9978 | +12,69% | €326,56M | €17,99K | |
FPH Five Point Holdings, LLC Class A Common Shares | €4,4829 | +2,20% | €325,96M | €76,46K | |
NAN Nuveen New York Quality Municipal Income Fund | €10,1876 | -0,17% | €325,75M | €45,39K | |
GBLI Global Indemnity Group, LLC Class A Common Stock | €22,2035 | +0,12% | €325,40M | €5,96K | |
| €12,5082 | +1,64% | €324,45M | €48,31K | |
SLP Simulations Plus, Inc. | €15,9582 | +0,30% | €324,12M | €556,10K | |
IFRX InflaRx N.V. Common Stock | €1,7009 | +1,84% | €323,67M | €627,81K | |
ENTA Enanta Pharmaceuticals, Inc | €12,3675 | +5,24% | €323,58M | €353,02K | |
LPRO Open Lending Corporation Common Stock | €2,7337 | -0,64% | €323,45M | €4,20M | |
| €29,3059 | +1,28% | €323,10M | €88,66K | |
FCRS FutureCrest Acquisition Corp. | €8,9570 | +0,10% | €322,84M | €36,55K | |
GIW GigCapital8 Corp. Class A Ordinary Shares | €8,8515 | +0,00% | €322,83M | €27,06K | |
NVCT Nuvectis Pharma, Inc. Common Stock | €15,4484 | +6,32% | €322,22M | €247,24K | |
NOA North American Construction Group Ltd. | €11,8665 | -0,59% | €322,08M | €55,34K | |
